A phase III study for the evaluation of the immunogenicity and reactogenicity of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 season Southern Hemisphere) in adults 18 years of age and above
Active, not recruitingRBR-4bfx9c
GlaxoSmithKline BiologicalsFlu
Start: 2015-04-29Updated: 2025-10-27